EyeGate Pharmaceuticals, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
SAVACassava Sciences, Inc. -6.90%49.690.0%$331.13m
VRXValeant Pharmaceuticals International, Inc. 0.25%28.5014.1%$167.70m
PRGOPerrigo Co. Plc -1.63%44.736.9%$131.09m
HZNPHorizon Therapeutics Plc -0.80%112.085.5%$127.22m
ICLRICON plc -0.01%275.042.8%$123.32m
CTLTCatalent, Inc. -0.03%128.902.0%$115.63m
JAZZJazz Pharmaceuticals Plc 2.54%140.702.1%$100.37m
UTHRUnited Therapeutics Corp. -0.28%187.0714.0%$64.01m
ARGXargenx SE -0.48%293.740.0%$52.27m
BHCBausch Health Cos., Inc. 0.25%28.500.0%$46.49m
AXSMAxsome Therapeutics, Inc. -1.28%40.101.8%$41.54m
GRVIGrove, Inc. -8.31%6.400.0%$36.76m
PCRXPacira Biosciences, Inc. -1.19%53.209.8%$32.21m
ENDPEndo International Plc 0.73%4.178.5%$31.75m
INDPIndaptus Therapeutics, Inc. -0.51%7.800.0%$27.93m

Company Profile

EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.